Embecta logo
Embecta
EMBC | NASDAQ
Chart Builder DCF Calculator
$6.25
-$0.21 (-3.25%)
At close: Nov 16, 2026, 4:00 PM ET
$6.25
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Embecta Company Profile

Company profile explained

Company Profile

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.

Key Executives

Name Position
Devdatt Kurdikar President, CEO & Chairman
Jacob Elguicze Senior Vice President & Chief Financial Officer
Anthony Roth Vice President, Chief Accounting Officer & Corporate Controller
Ginny Blocki Senior Vice President of Strategy
Jean Casner Senior Vice President & Chief Human Resources Officer
Jeffrey Z. Mann Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary
Pravesh Khandelwal Vice President & Head of Investor Relations
Shaun Curtis Senior Vice President of Global Manufacturing & Supply Chain
Slobodan Radumilo Senior Vice President & President of International
Tom Blount Senior Vice President & President of North America

Latest SEC Filings

Date Type Title
Sep 08, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 13, 2026 4 Filing
Aug 13, 2026 4 Filing
Aug 13, 2026 4 Filing
Aug 13, 2026 4 Filing
Aug 11, 2026 4 Filing
Aug 07, 2026 S-8 Filing
Aug 07, 2026 10-Q Quarterly Report
Aug 07, 2026 8-K Current Report
View All SEC Filings ➞
Embecta
Embecta logo
Country United States
IPO Date Mar 22, 2022
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 1,850
CEO Devdatt Kurdikar

Contact Details

300 Kimball Drive Parsippany, New Jersey 07054 United States

Stock Details

Ticker Symbol EMBC
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001872789
CUSIP Number 29082K105
ISIN Number US29082K1051
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.